Ozempic Vs. Glucose Monitors (feat. Sharam Fouladgar-Mercer) #685

Yet more GLP1 news this week. People regain on average 60% of their lost weight within a year of stopping GLP-1 drugs — and the regained weight may be disproportionately fat rather than muscle. So are a tool that biohackers have known about for years - CGMs - the answer? Sharam Fouladgar-Mercer is the co-founder of Signos, the first ever FDA-cleared glucose system for weight management. Follow Sharam Fouladgar-Mercer on LinkedIn.

You can listen to Ozempic Vs. Glucose Monitors (feat. Sharam Fouladgar-Mercer) #685 online on Radio and Podcast. Open the player on this page to stream the available audio.

Ozempic Vs. Glucose Monitors (feat. Sharam Fouladgar-Mercer) #685 is an episode from Zestology: Energy, vitality and motivation by Tony Wrighton.

This episode is 32:50 long.

This episode was published on Mar 30, 2026.

Yes. Use the heart button on the episode page to add it to your favorite episodes list.

Yes. This page shows related episodes from Zestology: Energy, vitality and motivation when more episodes are available from the podcast feed.